miR-30e-5p as predictor of generalization in ocular myasthenia gravis.
Liis SabrePaul MaddisonSui H WongGirija SadalagePhilip A AmbroseGordon T PlantAnna Rostedt PungaPublished in: Annals of clinical and translational neurology (2019)
This is the first study to describe a potential predictive factor associated with the risk of generalization for patients with OMG. Raised levels (>8) of miR-30e-5p at initial presentation in patients with ocular MG symptoms, give a predictive cut-off for subsequent generalization of 96-100%.